| Immune checkpoint inhibitors: new insights and current place in cancer therapy NM La‐Beck, GW Jean, C Huynh, SK Alzghari, DB Lowe Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (10 …, 2015 | 246 | 2015 |
| Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer GW Jean, SR Shah Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (6 …, 2008 | 122 | 2008 |
| Dosing considerations for obese patients receiving cancer chemotherapeutic agents RG Hall, GW Jean, M Sigler, S Shah Annals of Pharmacotherapy 47 (12), 1666-1674, 2013 | 41 | 2013 |
| Toxic effects of sorafenib in patients with differentiated thyroid carcinoma compared with other cancers GW Jean, RM Mani, A Jaffry, SA Khan JAMA oncology 2 (4), 529-534, 2016 | 29 | 2016 |
| Trends in the incidence and outcomes of hospitalized cancer patients with Clostridium difficile infection: a nationwide analysis A Gupta, R Tariq, RD Frank, GW Jean, MS Beg, DS Pardi, DH Johnson, ... Journal of the National Comprehensive Cancer Network 15 (4), 466-472, 2017 | 26 | 2017 |
| Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context AD Le, SK Alzghari, GW Jean, NM La-Beck Therapeutics and Clinical Risk Management, 223-236, 2017 | 23 | 2017 |
| Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid SR Shah, GW Jean, SV Keisner, SM Gressett Ussery, JE Dowell Supportive Care in Cancer 20, 87-93, 2012 | 20 | 2012 |
| Role of obinutuzumab in the treatment of chronic lymphocytic leukemia GW Jean, JM Comeau American Journal of Health-System Pharmacy 72 (11), 933-942, 2015 | 10 | 2015 |
| Venous thromboembolism treatment outcomes in cancer patients and effect of third-party payers on anticoagulant choice GW Jean, K Kelly, J Mathew, E Larumbe, R Hughes Supportive Care in Cancer, 2016 | 8 | 2016 |
| High Initiation of adjuvant hormonal therapy among uninsured stages I–III breast cancer patients treated in a safety-net healthcare system CC Murphy, JA Tiro, GW Jean, BA Balasubramian, CA Alvarez Journal of Women's Health 26 (6), 655-661, 2017 | 6 | 2017 |
| Retrospective analysis of the consequences of acid suppressive therapy on ketoconazole efficacy in advanced castration-resistant prostate cancer SV Keisner, SR Shah, GW Jean, SM Gressett Ussery, JE Dowell Annals of Pharmacotherapy 44 (10), 1538-1544, 2010 | 4 | 2010 |
| The role of elotuzumab in the treatment of relapsed or refractory multiple myeloma JM Comeau, K Kelly, GW Jean The Bulletin of the American Society of Hospital Pharmacists 75 (2), 55-66, 2018 | 3 | 2018 |
| Choroid plexus papilloma—A case highlighting the challenges of extrapolating pediatric chemotherapy regimens to adult populations SL Barman, GW Jean, WM Dinsfriend, DE Gerber Journal of Oncology Pharmacy Practice 22 (1), 170-174, 2016 | 2 | 2016 |
| Graft-versus-lymphoma effect plus vorinostat as successful approach in a case of refractory gastric peripheral T cell lymphoma, not otherwise specified, after reduced intensity … SS Devarakonda, JL Shahan, A Takalkar, SI Chaudhery, G Jean, ... Leukemia & Lymphoma 54 (11), 2545-2547, 2013 | 2 | 2013 |
| Response to ketoconazole after failure of docetaxel in patients with advanced androgen-independent prostate cancer (AIPC). GW Jean, S Shah, SV Keisner, SM GressettUssery, J Dowell Journal of Clinical Oncology 28 (15_suppl), e15052-e15052, 2010 | 1 | 2010 |
| Initiation of adjuvant hormonal therapy among uninsured stage I-III breast cancer patients treated in a safety-net healthcare system CC Murphy, JA Tiro, G Jean, BA Balasubramanian, RT Higashi, B Le, ... CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 25 (3), 2016 | | 2016 |
| Abstract C59: Initiation of adjuvant hormonal therapy among uninsured stage I-III breast cancer patients treated in a safety-net healthcare system CC Murphy, JA Tiro, G Jean, BA Balasubramanian, RT Higashi, B Le, ... Cancer Epidemiology, Biomarkers & Prevention 25 (3_Supplement), C59-C59, 2016 | | 2016 |
| Romiplostim for the treatment of a megakaryocytic thrombocytopenia secondary to remission-inducing immunomodulation in a patient with relapsing acute lymphoblastic leukemia … L Volodin, VK Bhanderi, J Shahan, C Leary, G Jean, J Comeau, ... Journal of Clinical Oncology 29 (15_suppl), 6609-6609, 2011 | | 2011 |
| An incidence of renal failure in patients receiving renally adjusted zoledronic acid. S Shah, GW Jean, SV Keisner, SM GressettUssery, J Dowell Journal of Clinical Oncology 28 (15_suppl), e19581-e19581, 2010 | | 2010 |
| A retrospective analysis of the consequences of acid suppressive therapy (AST) on ketoconazole (K) efficacy in advanced androgen-independent prostate cancer (AIPC). SV Keisner, S Shah, GW Jean, SM GressettUssery, J Dowell Journal of Clinical Oncology 28 (15_suppl), e15114-e15114, 2010 | | 2010 |
Saeed AlzghariTexas Health ResourcesVerified email at texashealth.org
